The University of Chicago Header Logo

Connection

Julie Fitzgerald to Adolescent

Back to Details
This is a "connection" page, showing publications Julie Fitzgerald has written about Adolescent.
Julie Fitzgerald
Connection Strength
1.576
Adolescent
  1. Association of continuous kidney replacement therapy timing and mortality in critically ill children. Pediatr Nephrol. 2024 Jul; 39(7):2217-2226.
    View in: PubMed
    Score: 0.096
  2. Risk of Mortality in Immunocompromised Children With Severe Sepsis and Septic Shock. Crit Care Med. 2020 07; 48(7):1026-1033.
    View in: PubMed
    Score: 0.075
  3. Vancomycin Prescribing and Therapeutic Drug Monitoring in Children With and Without Acute Kidney Injury After Cardiac Arrest. Paediatr Drugs. 2019 Apr; 21(2):107-112.
    View in: PubMed
    Score: 0.069
  4. Comparison of Methods for Identification of Pediatric Severe Sepsis and Septic Shock in the Virtual Pediatric Systems Database. Crit Care Med. 2019 02; 47(2):e129-e135.
    View in: PubMed
    Score: 0.068
  5. Risk factors and inpatient outcomes associated with acute kidney injury at pediatric severe sepsis presentation. Pediatr Nephrol. 2018 10; 33(10):1781-1790.
    View in: PubMed
    Score: 0.065
  6. Hospital Variation in Intensive Care Resource Utilization and Mortality in Newly Diagnosed Pediatric Leukemia. Pediatr Crit Care Med. 2018 06; 19(6):e312-e320.
    View in: PubMed
    Score: 0.065
  7. Association of Delayed Antimicrobial Therapy with One-Year Mortality in Pediatric Sepsis. Shock. 2017 07; 48(1):29-35.
    View in: PubMed
    Score: 0.061
  8. Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia. Crit Care Med. 2017 Feb; 45(2):e124-e131.
    View in: PubMed
    Score: 0.059
  9. Identification and transcriptomic assessment of latent profile pediatric septic shock phenotypes. Crit Care. 2024 Jul 17; 28(1):246.
    View in: PubMed
    Score: 0.025
  10. Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation. Nat Med. 2024 Jul; 30(7):1982-1993.
    View in: PubMed
    Score: 0.025
  11. Diagnostic Identification of Acute Brain Dysfunction in Pediatric Sepsis and Septic Shock in the Electronic Health Record: A Comparison of Four Definitions in a Reference Dataset. Pediatr Crit Care Med. 2024 Aug 01; 25(8):740-747.
    View in: PubMed
    Score: 0.024
  12. Extracorporeal Membrane Oxygenation Characteristics and Outcomes in Children and Adolescents With COVID-19 or Multisystem Inflammatory Syndrome Admitted to U.S. ICUs. Pediatr Crit Care Med. 2023 05 01; 24(5):356-371.
    View in: PubMed
    Score: 0.023
  13. Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020. JAMA Neurol. 2023 01 01; 80(1):91-98.
    View in: PubMed
    Score: 0.022
  14. NFKB2 haploinsufficiency identified via screening for IFN-a2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications. J Allergy Clin Immunol. 2023 04; 151(4):926-930.e2.
    View in: PubMed
    Score: 0.022
  15. Tachyarrhythmias During Hospitalization for COVID-19 or Multisystem Inflammatory Syndrome in Children and Adolescents. J Am Heart Assoc. 2022 10 18; 11(20):e025915.
    View in: PubMed
    Score: 0.022
  16. Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2 Infection. Pediatr Infect Dis J. 2022 11 01; 41(11):891-898.
    View in: PubMed
    Score: 0.022
  17. Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C. Pediatrics. 2022 09 01; 150(3).
    View in: PubMed
    Score: 0.022
  18. Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C. Nat Commun. 2022 05 27; 13(1):2979.
    View in: PubMed
    Score: 0.021
  19. Frequency, Characteristics and Complications of COVID-19 in Hospitalized Infants. Pediatr Infect Dis J. 2022 03 01; 41(3):e81-e86.
    View in: PubMed
    Score: 0.021
  20. Sepsis-Related Brain MRI Abnormalities Are Associated With Mortality and Poor Neurological Outcome in Pediatric Sepsis. Pediatr Neurol. 2022 03; 128:1-8.
    View in: PubMed
    Score: 0.021
  21. Life-Threatening Bleeding in Children: A Prospective Observational Study. Crit Care Med. 2021 11 01; 49(11):1943-1954.
    View in: PubMed
    Score: 0.021
  22. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes. N Engl J Med. 2021 07 01; 385(1):23-34.
    View in: PubMed
    Score: 0.020
  23. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2. JAMA Netw Open. 2021 06 01; 4(6):e2116420.
    View in: PubMed
    Score: 0.020
  24. Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. JAMA Neurol. 2021 05 01; 78(5):536-547.
    View in: PubMed
    Score: 0.020
  25. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021 03 16; 325(11):1074-1087.
    View in: PubMed
    Score: 0.020
  26. Integrating Focused Cardiac Ultrasound Into Pediatric Septic Shock Assessment. Pediatr Crit Care Med. 2021 03 01; 22(3):262-274.
    View in: PubMed
    Score: 0.020
  27. Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 07; 18(7):435-453.
    View in: PubMed
    Score: 0.020
  28. Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial. J Clin Oncol. 2021 03 10; 39(8):920-930.
    View in: PubMed
    Score: 0.019
  29. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv. 2020 12 08; 4(23):6051-6063.
    View in: PubMed
    Score: 0.019
  30. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. J Clin Invest. 2020 11 02; 130(11):5967-5975.
    View in: PubMed
    Score: 0.019
  31. Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome. Pediatr Blood Cancer. 2020 11; 67(11):e28693.
    View in: PubMed
    Score: 0.019
  32. Multisystem Inflammatory Syndrome in Children During the Coronavirus 2019 Pandemic: A Case Series. J Pediatric Infect Dis Soc. 2020 Jul 13; 9(3):393-398.
    View in: PubMed
    Score: 0.019
  33. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 2020 07 23; 383(4):334-346.
    View in: PubMed
    Score: 0.019
  34. Respiratory pathogens associated with intubated pediatric patients following hematopoietic cell transplant. Transpl Infect Dis. 2020 Aug; 22(4):e13297.
    View in: PubMed
    Score: 0.019
  35. Implementation of a Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: the Optimizing Antibiotic Strategies in Sepsis (OASIS) II Study. J Pediatric Infect Dis Soc. 2020 Feb 28; 9(1):36-43.
    View in: PubMed
    Score: 0.018
  36. Identification of Pediatric Sepsis for Epidemiologic Surveillance Using Electronic Clinical Data. Pediatr Crit Care Med. 2020 02; 21(2):113-121.
    View in: PubMed
    Score: 0.018
  37. Matched Retrospective Cohort Study of Thiamine to Treat Persistent Hyperlactatemia in Pediatric Septic Shock. Pediatr Crit Care Med. 2019 09; 20(9):e452-e456.
    View in: PubMed
    Score: 0.018
  38. Major Adverse Kidney Events in Pediatric Sepsis. Clin J Am Soc Nephrol. 2019 05 07; 14(5):664-672.
    View in: PubMed
    Score: 0.017
  39. The Association of Nutrition Status Expressed as Body Mass Index z Score With Outcomes in Children With Severe Sepsis: A Secondary Analysis From the Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study. Crit Care Med. 2018 11; 46(11):e1029-e1039.
    View in: PubMed
    Score: 0.017
  40. Acute Respiratory Failure in Pediatric Hematopoietic Cell Transplantation: A Multicenter Study. Crit Care Med. 2018 10; 46(10):e967-e974.
    View in: PubMed
    Score: 0.017
  41. Acute kidney injury after out of hospital pediatric cardiac arrest. Resuscitation. 2018 10; 131:63-68.
    View in: PubMed
    Score: 0.016
  42. Hypofibrinogenemia Is Associated With Poor Outcome and Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in Pediatric Severe Sepsis. Pediatr Crit Care Med. 2018 05; 19(5):397-405.
    View in: PubMed
    Score: 0.016
  43. High-Frequency Oscillatory Ventilation Use and Severe Pediatric ARDS in the Pediatric Hematopoietic Cell Transplant Recipient. Respir Care. 2018 Apr; 63(4):404-411.
    View in: PubMed
    Score: 0.016
  44. High Levels of Morbidity and Mortality Among Pediatric Hematopoietic Cell Transplant Recipients With Severe Sepsis: Insights From the Sepsis PRevalence, OUtcomes, and Therapies International Point Prevalence Study. Pediatr Crit Care Med. 2017 Dec; 18(12):1114-1125.
    View in: PubMed
    Score: 0.016
  45. Identifying Risk for Acute Kidney Injury in Infants and Children Following Cardiac Arrest. Pediatr Crit Care Med. 2017 Oct; 18(10):e446-e454.
    View in: PubMed
    Score: 0.015
  46. The Epidemiology of Hospital Death Following Pediatric Severe Sepsis: When, Why, and How Children With Sepsis Die. Pediatr Crit Care Med. 2017 Sep; 18(9):823-830.
    View in: PubMed
    Score: 0.015
  47. Improving Recognition of Pediatric Severe Sepsis in the Emergency Department: Contributions of a Vital Sign-Based Electronic Alert and Bedside Clinician Identification. Ann Emerg Med. 2017 Dec; 70(6):759-768.e2.
    View in: PubMed
    Score: 0.015
  48. A Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: The Optimizing Antibiotic Strategies in Sepsis (OASIS) Study. J Pediatric Infect Dis Soc. 2017 Jun 01; 6(2):134-141.
    View in: PubMed
    Score: 0.015
  49. Pediatric Acute Respiratory Distress Syndrome in Pediatric Allogeneic Hematopoietic Stem Cell Transplants: A Multicenter Study. Pediatr Crit Care Med. 2017 Apr; 18(4):304-309.
    View in: PubMed
    Score: 0.015
  50. Crystalloid Fluid Choice and Clinical Outcomes in Pediatric Sepsis: A Matched Retrospective Cohort Study. J Pediatr. 2017 03; 182:304-310.e10.
    View in: PubMed
    Score: 0.015
  51. New or Progressive Multiple Organ Dysfunction Syndrome in Pediatric Severe Sepsis: A Sepsis Phenotype With Higher Morbidity and Mortality. Pediatr Crit Care Med. 2017 01; 18(1):8-16.
    View in: PubMed
    Score: 0.015
  52. Protocolized Treatment Is Associated With Decreased Organ Dysfunction in Pediatric Severe Sepsis. Pediatr Crit Care Med. 2016 09; 17(9):817-22.
    View in: PubMed
    Score: 0.014
  53. Comparison of Pediatric Severe Sepsis Managed in U.S. and European ICUs. Pediatr Crit Care Med. 2016 06; 17(6):522-30.
    View in: PubMed
    Score: 0.014
  54. Supportive care utilization and treatment toxicity in children with Down syndrome and acute lymphoid leukaemia at free-standing paediatric hospitals in the United States. Br J Haematol. 2016 08; 174(4):591-9.
    View in: PubMed
    Score: 0.014
  55. Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia. Cancer Discov. 2016 06; 6(6):664-79.
    View in: PubMed
    Score: 0.014
  56. Optimizing Virus Identification in Critically Ill Children Suspected of Having an Acute Severe Viral Infection. Pediatr Crit Care Med. 2016 Apr; 17(4):279-86.
    View in: PubMed
    Score: 0.014
  57. Invasive Mechanical Ventilation and Mortality in Pediatric Hematopoietic Stem Cell Transplantation: A Multicenter Study. Pediatr Crit Care Med. 2016 Apr; 17(4):294-302.
    View in: PubMed
    Score: 0.014
  58. Pediatric Severe Sepsis/Septic Shock Associated with Healthcare-Associated Infections. Infect Control Hosp Epidemiol. 2016 Apr; 37(4):483-5.
    View in: PubMed
    Score: 0.014
  59. Prospective Testing and Redesign of a Temporal Biomarker Based Risk Model for Patients With Septic Shock: Implications for Septic Shock Biology. EBioMedicine. 2015 Dec; 2(12):2087-93.
    View in: PubMed
    Score: 0.014
  60. Comparison of Two Sepsis Recognition Methods in a Pediatric Emergency Department. Acad Emerg Med. 2015 Nov; 22(11):1298-306.
    View in: PubMed
    Score: 0.014
  61. Discordant identification of pediatric severe sepsis by research and clinical definitions in the SPROUT international point prevalence study. Crit Care. 2015 Sep 16; 19:325.
    View in: PubMed
    Score: 0.013
  62. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015 May 15; 191(10):1147-57.
    View in: PubMed
    Score: 0.013
  63. Implementation of a pediatric critical care focused bedside ultrasound training program in a large academic PICU. Pediatr Crit Care Med. 2015 Mar; 16(3):219-26.
    View in: PubMed
    Score: 0.013
  64. Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis. Crit Care Med. 2014 Nov; 42(11):2409-17.
    View in: PubMed
    Score: 0.013
  65. Association of weekend admission with hospital length of stay, time to chemotherapy, and risk for respiratory failure in pediatric patients with newly diagnosed leukemia at freestanding US children's hospitals. JAMA Pediatr. 2014 Oct; 168(10):925-31.
    View in: PubMed
    Score: 0.013
  66. Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States. Pediatr Crit Care Med. 2014 Feb; 15(2):112-20.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.